Search results

Eli Lilly's director of alliance management tells how the company has learned to make a success of its partnership strategy.

The author describes best practices and key principles.

The Lilly process has proven successful – of the last six products the firm has launched, four are promoted with a partner.

Lilly has developed a “three‐dimensional fit” analysis that helps the firm identify elements of strategic fit, cultural fit and operational fit between Lilly and a partner company.

Lilly describes how the elements of their alliance program increase the likelihood of success for individual partnerships and how a continuous learning process contributes to the success of future alliances.

The paper aims to review the latest management developments across the globe and pinpoints practical implications from cutting‐edge research and case studies.

This briefing is prepared by an independent writer who adds their own impartial comments and places the articles in context.

Eli Lilly and Company is a global pharmaceutical company and one of the world's largest corporations. Following a major strategic review during the 1990s, Eli senior executives chose to focus on developing strong organic growth rather than expanding through mergers and acquisitions.

The paper provides strategic insights and practical thinking that have influenced some of the world's leading organizations.

The briefing saves busy executives and researchers hours of reading time by selecting only the very best, most pertinent information and presenting it in a condensed and easy‐to‐digest format.